EMIS is a clinical software supplier to the UK healthcare market. The company was originally established to serve the GP market, where it has a leading position with a market share of 57% of UK GP practices. It has expanded from this position to create a broad range of products serving the community healthcare market, the acute sector and community pharmacies (where it has c 37% share) as well specialist software and screening services for diabetic retinopathy. Its Patient business provides medical and wellbeing information as well as transactional services to patients. The company strategy is to provide connected healthcare solutions to facilitate patient-centric care.
In this video, CEO Andy Thorburn reviews the company’s FY18 results and gives an overview of performance at a divisional level. He gives an update on the GP software procurement process in England and highlights that the company was selected for the next Scottish GP software framework. He gives a progress update on the development of the EMIS-X platform. Finally, he discusses the current trading environment and gives his views on the company’s short- and medium-term outlook.